Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging

Papers of special note have been highlighted as either of interest (•) or of considerable interest (••) to readers.

Bibliography

• 1  Chan WCW, Maxwell DJ, Gao XH, Bailey RE, Han MY, Nie SM: Luminescent quantum dots for multiplexed biological detection and imaging. Curr. Opin. Biotechnol.13,40–46 (2002).
  Medline CASGoogle Scholar
• 2  Bruchez M, Moronne M, Gin P, Weiss S, Alivisatos AP: Semiconductor nanocrystals as fluorescent biological labels. Science281,2013–2016 (1998).• Seminal paper demonstrating that semiconductor quantum dots (QDs) can be solubilized in aqueous solution and can be conjugated to biomolecules for biolabeling applications.
  Medline CASGoogle Scholar
• 3  Chan WCW, Nie SM: Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science281,2016–2018 (1998).• Seminal paper that demonstrates the feasibility of preparing and using QD bioconjugates for ultrasensitive detection and imaging.
  Medline CASGoogle Scholar
• 4  Mattoussi H, Mauro JM, Goldman ER et al.: Self-assembly of CdSe–ZnS quantum dot bioconjugates using an engineered recombinant protein. J. Am. Chem. Soc.122,12142–12150 (2000).
  CASGoogle Scholar
• 5  Akerman ME, ChanWCW, Laakkonen P, Bhatia SN, Ruoslahti E: Nanocrystal targeting in vivo. Proc. Natl Acad. Sci. USA99,12617–12621 (2002).
  Medline CASGoogle Scholar
• 6  Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A: In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science298,1759–1762 (2002).•• Reports the development of lipid-encapsulated QDs for in vivo imaging in live organisms. These dots are remarkable stable and biocompatible.
  Medline CASGoogle Scholar
• 7  Wu XY, Liu HJ, Liu JQ et al.: Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat. Biotechnol.21,41–46 (2003).• Reports the use of amphiphilic polymers for solubilizing QDs and the conjugation of antibodies to the polymer coating. The results demonstrate high-quality multicolor staining of cancer cells with bioconjugated QD probes.
  Medline CASGoogle Scholar
• 8  Jaiswal JK, Mattoussi H, Mauro JM, Simon SM: Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat. Biotechnol.21,47–51 (2003).
  Medline CASGoogle Scholar
• 9  Larson DR, Zipfel WR, Williams RM et al.: Water-soluble quantum dots for multiphoton fluorescence imaging in vivo.Science300,1434–1436 (2003).
  Medline CASGoogle Scholar
• 10  Ishii D, Kinbara K, Ishida Y et al.: Chaperonin-mediated stabilization and ATP-triggered release of semiconductor nanoparticles. Nature423,628–632 (2003).
  Medline CASGoogle Scholar
• 11  Medintz IL, Clapp AR, Mattoussi H, Goldman ER, Fisher B, Mauro JM: Self-assembled nanoscale biosensors based on quantum dot FRET donors. Nat. Mater.2,630–638 (2003).
  Medline CASGoogle Scholar
• 12  Dahan M, Levi S, Luccardini C, Rostaing P, Riveau B, Triller A: Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking. Science302,442–445 (2003).•• Demonstrates that QD probes can be used to image and track individual receptor molecules on the surface of live cells (neurons).
  Medline CASGoogle Scholar
• 13  Lidke DS, Nagy P, Heintzmann R et al.: Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction. Nat. Biotechnol.22,198–203 (2004).•• Describes the use of antibody-conjugated QDs to study receptor endocytosis in unprecedented details.
  Medline CASGoogle Scholar
• 14  Smith A, Ruan G, Rhyner MN, Nie SM: Engineering luminescent quantum dots for in vivo molecular and cellular imaging. Ann. Biomed. Eng.34,1–12 (2006).
  Google Scholar
• 15  Gao XH, Yang LL, Petros JA, Marshal FF, Simons JW, Nie SM: In vivo molecular and cellular imaging with quantum dots. Curr. Opin. Biotechnol.16,63–72 (2005).
  Medline CASGoogle Scholar
• 16  Smith AM, Gao XH, Nie SM: Quantum dot nanocrystals for in vivo molecular and cellular imaging. Photochem. Photobiol.80,377–385 (2004).
  Medline CASGoogle Scholar
• 17  Pinaud F, Michalet X, Bentolila LA et al.: Advances in fluorescence imaging with quantum dot bio-probes. Biomaterials27,1679–1687 (2006).
  Medline CASGoogle Scholar
• 18  Alivisatos AP, Gu WW, Larabell C: Quantum dots as cellular probes. Annu. Rev. Biomed. Eng.7,55–76 (2005).
  Medline CASGoogle Scholar
• 19  Michalet X, Pinaud FF, Bentolila LA et al.: Quantum dots for live cells, in vivo imaging, and diagnostics. Science307,538–544 (2005).
  Medline CASGoogle Scholar
• 20  Stroh M, Zimmer JP, Duda DG et al.: Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo.Nat. Med.11,678–682 (2005).
  Medline CASGoogle Scholar
• 21  Goldman ER, Medintz IL, Whitley JL et al.: A hybrid quantum dot-antibody fragment fluorescence resonance energy transfer-based TNT sensor. J. Am. Chem. Soc.127,6744–6751 (2005).
  Medline CASGoogle Scholar
• 22  Josephson L, Tung CH, Moore A, Weissleder R: High-efficiency intracellular magnetic labeling with novel superparamagnetic-tat peptide conjugates. Bioconjug. Chem.10,186–191 (1999).
  Medline CASGoogle Scholar
• 23  Bulte JWM, Douglas T, Witwer B et al.: Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol.19,1141–1147 (2001).
  Medline CASGoogle Scholar
• 24  Curtis A, Wilkinson C: Nantotechniques and approaches in biotechnology. Trends Biotechnol.19,97–101 (2001).
  Medline CASGoogle Scholar
• 25  Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R: Biodegradable long-circulating polymeric nanospheres. Science263,1600–1603 (1994).
  Medline CASGoogle Scholar
• 26  Alivisatos AP: Semiconductor clusters, nanocrystals, and quantum dots. Science271,933–937 (1996).
  CASGoogle Scholar
• 27  Duncan R, Discovery NRD: The dawning era of polymer therapeutics. Nat. Rev. Drug Discov.2,347–360 (2003).
  Medline CASGoogle Scholar
• 28  Jain RK: Understanding barriers to drug delivery: high resolution in vivo imaging is key. Clin. Cancer Res.5,1605–1606 (1999).
  Medline CASGoogle Scholar
• 29  Jain RK: Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J. Control. Release74,7–25 (2001).
  Medline CASGoogle Scholar
• 30  Lemon BI, Crooks RM: Preparation and characterization of dendrimer-encapsulated CdS semiconductor quantum dots. J. Am. Chem. Soc.122,12886–12887 (2000).
  CASGoogle Scholar
• 31  Murray CB, Sun SH, Gaschler W, Doyle H, Betley TA, Kagan CR: Colloidal synthesis of nanocrystals and nanocrystal superlattices. IBM. J. Res. Dev.45,47–56 (2001).
  CASGoogle Scholar
• 32  Rogach A, Kershaw S, Burt M et al.: Colloidally prepared HgTe nanocrystals with strong room-temperature infrared luminescence. Adv. Mater. Weinheim11,552 (1999).
  CASGoogle Scholar
• 33  Gao XH, Nie SM: Doping mesoporous materials with multicolor quantum dots. J. Phys. Chem. B107,11575–11578 (2003).
  CASGoogle Scholar
• 34  Han MY, Gao XH, Su JZ, Nie S: Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules. Nat. Biotechnol.19,631–635 (2001).
  Medline CASGoogle Scholar
• 35  Yu WW, Qu LH, Guo WZ, Peng XG: Experimental determination of the extinction coefficient of CdTe, CdSe, and CdS nanocrystals. Chem. Mater.15,2854–2860 (2003).
  CASGoogle Scholar
• 36  Kim SW, Zimmer JP, Ohnishi S, Tracy JB, Frangioni JV, Bawendi MG: Engineering InAsxP1-x/InP/ZnSe III–V alloyed core/shell quantum dots for the near-infrared. J. Am. Chem. Soc.127,10526–10532 (2005).
  Medline CASGoogle Scholar
• 37  Gao XH, Cui YY, Levenson RM, Chung LWK, Nie SM: In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol.22,969–976 (2004).•• Reports a new class of multifunctional QD probe for simultaneous tumor targeting and imaging in live animal models. The structural design involves encapsulating luminescent QDs with an ABC triblock copolymer and linking this amphiphilic polymer to tumor-targeting ligands and drug-delivery functionalities. In vivo targeting studies of human prostate cancer growing in nude mice indicate that the QD probes can be delivered to tumor sites by enhanced permeation and retention and by antibody binding to cancer-specific cell surface biomarkers.
  Medline CASGoogle Scholar
• 38  Weissleder R, Kelly K, Sun EY, Shtatland T, Josephson L: Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat. Biotechnol.23,1418–1423 (2005).
  Medline CASGoogle Scholar
• 39  Caplan MR, Rosca EV: Targeting drugs to combinations of receptors: a modeling analysis of potential specificity. Ann. Biomed. Eng.33,1113–1124 (2005).
  MedlineGoogle Scholar
• 40  Vu TQ, Maddipati R, Blute TA, Nehilla BJ, Nusblat L, Desai TA: Peptide-conjugated quantum dots activate neuronal receptors and initiate downstream signaling of neurite growth. Nano Lett.5,603–607 (2005).
  Medline CASGoogle Scholar
• 41  Fu AH, Micheel CM, Cha J, Chang H, Yang H, Alivisatos AP: Discrete nanostructures of quantum dots/Au with DNA. J. Am. Chem. Soc.126,10832–10833 (2004).
  Medline CASGoogle Scholar
• 42  Nehilla BJ, Vu TQ, Desai TA: Stoichiometry-dependent formation of quantum dot-antibody bioconjugates: a complementary atomic force microscopy and agarose gel electrophoresis study. J. Phys. Chem. B109,20724–20730 (2005).
  Medline CASGoogle Scholar
• 43  Ntziachristos V, Bremer C, Weissleder R: Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur. Radiol.13,195–208 (2003).
  MedlineGoogle Scholar
• 44  Ntziachristos V, Schellenberger EA, Ripoll J et al.: Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc. Natl Acad. Sci. USA101,12294–12299 (2004).
  Medline CASGoogle Scholar
• 45  Kircher MF, Weissleder R, Josephson L: A dual fluorochrome probe for imaging proteases. Bioconjug. Chem.15,242–248 (2004).
  Medline CASGoogle Scholar
• 46  Schellenberger EA, Sosnovik D, Weissleder R, Josephson L: Magneto/optical annexin V, a multimodal protein. Bioconjug. Chem.15,1062–1067 (2004).
  Medline CASGoogle Scholar
• 47  Wang DS, He JB, Rosenzweig N, Rosenzweig Z: Superparamagnetic Fe₂O₃ beads–CdSe/ZnS quantum dots core-shell nanocomposite particles for cell separation. Nano Lett.4,409–413 (2004).
  CASGoogle Scholar
• 48  Gu HW, Zheng RK, Zhang XX, Xu B: Facile one-pot synthesis of bifunctional heterodimers of nanoparticles: a conjugate of quantum dot and magnetic nanoparticles. J. Am. Chem. Soc.126,5664–5665 (2004).
  Medline CASGoogle Scholar
• 49  Patri AK, Myc A, Beals J, Thomas TP, Bander NH, Baker JR: Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy. Bioconjug. Chem.15,1174–1181 (2004).
  Medline CASGoogle Scholar
• 50  Mulder WJ, Koole R, Brandwijk RJ et al.: Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano Lett.6,1–6 (2006).
  Medline CASGoogle Scholar
• 51  van Tilborg GAF, Mulder WJM, Chin PTK et al.: Annexin A5-conjugated quantum dots with a paramagnetic lipidic coating for the multimodal detection of apoptotic cells. Bioconjug. Chem.17,865–868 ( 2006).
  Medline CASGoogle Scholar
• 52  Quintana A, Raczka E, Piehler L et al.: Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm. Res.19,1310–1316 (2002).
  Medline CASGoogle Scholar
• 53  Torchilin VP, Trubetskoy VS, Milshteyn AM et al.: Targeted delivery of diagnostic agents by surface-modified liposomes. J. Control. Release28,45–58 (1994).
  CASGoogle Scholar
• 54  Torchilin V, Babich J, Weissig V: Liposomes and micelles to target the blood pool for imaging purposes. J. Liposome Res.10,483–499 (2000).
  CASGoogle Scholar
• 55  Buck SM, Koo YEL, Park E et al.: Optochemical nanosensor PEBBLEs: photonic explorers for bioanalysis with biologically localized embedding. Curr. Opin. Chem. Biol.8,540–546 (2004).
  Medline CASGoogle Scholar
• 56  Voura EB, Jaiswal JK, Mattoussi H, Simon SM: Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat. Med.10,993–998 (2004).
  Medline CASGoogle Scholar
• 57  Hoshino A, Hanaki K, Suzuki K, Yamamoto K: Applications of T-lymphoma labeled with fluorescent quantum dots to cell tracing markers in mouse body. Biochem. Biophys. Res. Commun.314,46–53 (2004).
  Medline CASGoogle Scholar
• 58  Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS: Noninvasive imaging of quantum dots in mice. Bioconjug. Chem.15,79–86 (2004).• Significant paper that carefully examines the in vivo behavior of injected QDs into live mice.
  Medline CASGoogle Scholar
• 59  Kim S, Lim YT, Soltesz EG et al.: Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat. Biotechnol.22,93–97 (2004).•• Uses near-infrared-emitting QDs (Type II) for in vivo fluorescence imaging of lymph nodes.
  Medline CASGoogle Scholar
• 60  Parungo CP, Colson YL, Kim SW et al.: Sentinel lymph node mapping of the pleural space. Chest127,1799–1804 (2005).
  MedlineGoogle Scholar
• 61  Soltesz EG, Kim S, Laurence RG et al.: Intraoperative sentinel lymph node mapping of the lung using near-infrared fluorescent quantum dots. Ann. Thorac. Surg.79,269–277 (2005).
  MedlineGoogle Scholar
• 62  So MK, Xu CJ, Loening AM, Gambhir SS, Rao JH: Self-illuminating quantum dot conjugates for in vivo imaging. Nat. Biotechnol.24,339–343 (2006).
  Medline CASGoogle Scholar
• 63  Bander NH, Trabulsi EJ, Kostakoglu L et al.: Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen. J. Urol.170,1717–1721 (2003).
  Medline CASGoogle Scholar
• 64  Cai WB, Shin DW, Chen K et al.: Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett.6,669–676 (2006).
  Medline CASGoogle Scholar
• 65  Goldman ER, Clapp AR, Anderson GP et al.: Multiplexed toxin analysis using four colors of quantum dot fluororeagents. Anal. Chem.76,684–688 (2004).
  Medline CASGoogle Scholar
• 66  Lingerfelt BM, Mattoussi H, Goldman ER, Mauro JM, Anderson GP: Preparation of quantum dot–biotin conjugates and their use in immunochromatography assays. Anal. Chem.75,4043–4049 (2003).
  Medline CASGoogle Scholar
• 67  Medintz IL, Konnert JH, Clapp AR et al.: A fluorescence resonance energy transfer-derived structure of a quantum dot-protein bioconjugate nanoassembly. Proc. Natl Acad. Sci. USA101,9612–9617 (2004).
  Medline CASGoogle Scholar
• 68  Lovric J, Bazzi HS, Cuie Y, Fortin GRA, Winnik FM, Maysinger D: Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J. Mol. Med.83,377–385 (2005).
  MedlineGoogle Scholar
• 69  Hoshino A, Fujioka K, Oku T et al.: Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification. Nanoletters4,2163–2169 (2004).
  CASGoogle Scholar
• 70  Derfus AM, Chan WCW, Bhatia SN: Probing the cytotoxicity of semiconductor quantum dots. Nano Lett.4,11–18 (2004).• One of the first important papers to examine the potential toxicities of semiconductor QDs in living cell imaging applications.
  Medline CASGoogle Scholar
• 71  Ipe BI, Lehnig M, Niemeyer CM: On the generation of free radical species from quantum dots. Small1,706–709 (2005).
  Medline CASGoogle Scholar
• 72  Kirchner C, Liedl T, Kudera S et al.: Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett.5,331–338 (2005).
  Medline CASGoogle Scholar